TACE

Clinical trials for TACE explained in plain language.

Never miss a new study

Get alerted when new TACE trials appear

Sign up with your email to follow new studies for TACE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 2

Liver cancer trial aims to boost immunotherapy with targeted chemo

Disease control Not yet recruiting

This phase 2 trial tests whether adding a targeted chemo procedure (TACE) to standard immunotherapy can improve outcomes for people with unresectable liver cancer. About 90 participants will receive either atezolizumab/bevacizumab or durvalumab/tremelimumab plus TACE. The goal is…

Matched conditions: TACE

Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control

Last updated Aug 08, 2026 00:03 UTC

TACE

Get alerted when new TACE trials appear

Liver cancer trial aims to boost immunotherapy with targeted chemo